Core A: Administrative

摘要-核心A(管理核心) 艰难梭菌抑制信使核糖核酸疫苗计划(MVACS)由一个高度互动的团队组成 研究人员正在寻求开发一种mRNA疫苗平台，以提供对 艰难梭状芽胞杆菌相关感染和疾病。项目1是生成和测试的引擎 改良的信使核糖核酸疫苗(项目1-疫苗开发)。这一努力得到了加速和指导 探索菌株多样性和微生物生态的项目(项目2--抗原发现)和粘膜 对自然感染的适应性免疫反应(项目3--免疫学)。支持这三个项目的是 两个科学核心，将提供专业知识、技术技能和对大型深度测序数据集的分析 (核心B-基因组核心)，并为患者队列收集样本(核心C-临床核心)。核心A (管理核心)是计划的后勤和组织部分，将处理定期 项目间沟通，并确保数据和信息的无缝交换。核心A(行政管理 CORE)由mVACS项目主任布什曼博士和魏斯曼博士共同领导。他们的主要目标是 监督计划的科学进展，监督资源的分配，刺激项目 交互和数据集成，确保遵守NIH指南，并促进科学事业 MVACS团队的发展。

SUMMARY – CORE A (Administration Core) The "mRNA Vaccines for C. difficile Suppression” program (mVACS) consists of a highly interactive team of investigators who are seeking to develop an mRNA vaccine platform to provide protection against Clostridioides difficile-associated infection and disease. Project 1 is the engine for generating and testing modified mRNA vaccines (Project 1 – Vaccine Development). This effort is accelerated and guided by projects exploring strain diversity and microbial ecology (Project 2 – Antigen Discovery) and the mucosal adaptive immune response to natural infection (Project 3 – Immunology). Supporting these three projects are two scientific cores that will provide expertise, technical skills, and analysis of large deep-sequencing datasets (Core B - Genomics Core), and collect samples for a patient cohort (Core C - Clinical Core). Core A (Administrative Core) is the logistical and organizational component of the program that will handle regular inter-project communication and ensure seamless exchange of data and information. Core A (Administrative Core) is co-led by the mVACS program directors Dr. Bushman and Dr. Weissman. Their primary objectives will be to monitor the scientific progress of the program, oversee distribution of resources, stimulate project interactions and data integration, ensure compliance with NIH guidelines, and promote the scientific career development of the mVACS team.